- Home
- BNR vs OPAD Comparison
BNR vs OPAD Comparison
Compare BNR & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- OPAD
- Stock Information
- Founded
- BNR 2014
- OPAD 2015
- Country
- BNR China
- OPAD United States
- Employees
- BNR N/A
- OPAD N/A
- Industry
- BNR Medical Specialities
- OPAD Real Estate
- Sector
- BNR Health Care
- OPAD Finance
- Exchange
- BNR Nasdaq
- OPAD Nasdaq
- Market Cap
- BNR 38.3M
- OPAD 25.3M
- IPO Year
- BNR 2020
- OPAD N/A
- Fundamental
- Price
- BNR $4.85
- OPAD $1.52
- Analyst Decision
- BNR
- OPAD Hold
- Analyst Count
- BNR 0
- OPAD 5
- Target Price
- BNR N/A
- OPAD $2.38
- AVG Volume (30 Days)
- BNR 20.0K
- OPAD 144.5K
- Earning Date
- BNR 08-21-2025
- OPAD 08-04-2025
- Dividend Yield
- BNR N/A
- OPAD N/A
- EPS Growth
- BNR N/A
- OPAD N/A
- EPS
- BNR N/A
- OPAD N/A
- Revenue
- BNR $72,112,038.00
- OPAD $794,159,000.00
- Revenue This Year
- BNR $136.32
- OPAD N/A
- Revenue Next Year
- BNR N/A
- OPAD $40.79
- P/E Ratio
- BNR N/A
- OPAD N/A
- Revenue Growth
- BNR 0.53
- OPAD N/A
- 52 Week Low
- BNR $2.18
- OPAD $0.91
- 52 Week High
- BNR $7.90
- OPAD $5.13
- Technical
- Relative Strength Index (RSI)
- BNR 74.01
- OPAD 64.86
- Support Level
- BNR $3.06
- OPAD $1.31
- Resistance Level
- BNR $4.96
- OPAD $1.52
- Average True Range (ATR)
- BNR 0.22
- OPAD 0.14
- MACD
- BNR 0.13
- OPAD 0.04
- Stochastic Oscillator
- BNR 84.74
- OPAD 69.32
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.